What is the current valuation of the Blood Purification Equipment Market?

The Blood Purification Equipment Market was valued at 12.06 USD Billion in 2024. Read More

What is the projected market size for the Blood Purification Equipment Market by 2035?

The market is projected to reach 32.96 USD Billion by 2035. Read More

What is the expected CAGR for the Blood Purification Equipment Market during the forecast period 2025 - 2035?

The expected CAGR for the market during 2025 - 2035 is 9.57%. Read More

Which application segment is anticipated to have the highest growth in the Blood Purification Equipment Market?

The Dialysis application segment is expected to grow from 7.0 USD Billion in 2024 to 18.5 USD Billion by 2035. Read More

Which blood filter material segment shows the most potential for growth?

The Polyethersulfone segment is projected to grow from 3.0 USD Billion in 2024 to 8.0 USD Billion by 2035. Read More

What is the anticipated market size for hospitals as an end user in the Blood Purification Equipment Market?

The hospitals segment is expected to grow from 4.82 USD Billion in 2024 to 13.25 USD Billion by 2035. Read More

How does the market for portable blood purification equipment compare to non-portable options?

The portable segment is projected to increase from 3.62 USD Billion in 2024 to 10.0 USD Billion by 2035, while non-portable equipment is expected to grow from 8.44 USD Billion to 22.96 USD Billion. Read More

Who are the leading companies in the Blood Purification Equipment Market?

Key players include Fresenius Medical Care, Baxter International, Nipro Corporation, and Medtronic. Read More

What trends are influencing the Blood Purification Equipment Market?

Trends include advancements in technology, increasing prevalence of renal diseases, and a growing demand for home-based treatment options. Read More

Blood Purification Equipment Market

Q: What are the key types of blood purification methods in the market?

The key types include Hemodialysis, Peritoneal Dialysis, Continuous Renal Replacement Therapy, and Intermittent Hemodialysis. Read More

ID: MRFR/MED/7566-HCR

128 Pages

Satyendra Maurya

Last Updated: May 15, 2026

Blood Purification Equipment Market Research Report By Application (Dialysis, Hemoperfusion, Plasmapheresis, Filtration), By Blood Purification Type (Hemodialysis, Peritoneal Dialysis, Continuous Renal Replacement Therapy, Intermittent Hemodialysis), By Blood Filter Material (Polyarylethersulfone, Cellulose Cellulose Acetate, Polyethersulfone, Polysulfone), By End User (Hospitals, Dialysis Clinics, Ambulatory Care Centers, Home Use), By Portability (Portable, Non-Portable) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Blood Purification Equipment Market Infographic

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Billion) | |
  1. 4.1.1 Dialysis | |
  2. 4.1.2 Hemoperfusion | |
  3. 4.1.3 Plasmapheresis | |
  4. 4.1.4 Filtration |
2. 4.2 Healthcare, BY Blood Purification Type (USD Billion) | |
  1. 4.2.1 Hemodialysis | |
  2. 4.2.2 Peritoneal Dialysis | |
  3. 4.2.3 Continuous Renal Replacement Therapy | |
  4. 4.2.4 Intermittent Hemodialysis |
3. 4.3 Healthcare, BY Blood Filter Material (USD Billion) | |
  1. 4.3.1 Polyarylethersulfone | |
  2. 4.3.2 Cellulose Cellulose Acetate | |
  3. 4.3.3 Polyethersulfone | |
  4. 4.3.4 Polysulfone |
4. 4.4 Healthcare, BY End User (USD Billion) | |
  1. 4.4.1 Hospitals | |
  2. 4.4.2 Dialysis Clinics | |
  3. 4.4.3 Ambulatory Care Centers | |
  4. 4.4.4 Home Use |
5. 4.5 Healthcare, BY Portability (USD Billion) | |
  1. 4.5.1 Portable | |
  2. 4.5.2 Non-Portable |
6. 4.6 Healthcare, BY Region (USD Billion) | |
  1. 4.6.1 North America | | |
    1. 4.6.1.1 US | | |
    2. 4.6.1.2 Canada | |
  2. 4.6.2 Europe | | |
    1. 4.6.2.1 Germany | | |
    2. 4.6.2.2 UK | | |
    3. 4.6.2.3 France | | |
    4. 4.6.2.4 Russia | | |
    5. 4.6.2.5 Italy | | |
    6. 4.6.2.6 Spain | | |
    7. 4.6.2.7 Rest of Europe | |
  3. 4.6.3 APAC | | |
    1. 4.6.3.1 China | | |
    2. 4.6.3.2 India | | |
    3. 4.6.3.3 Japan | | |
    4. 4.6.3.4 South Korea | | |
    5. 4.6.3.5 Malaysia | | |
    6. 4.6.3.6 Thailand | | |
    7. 4.6.3.7 Indonesia | | |
    8. 4.6.3.8 Rest of APAC | |
  4. 4.6.4 South America | | |
    1. 4.6.4.1 Brazil | | |
    2. 4.6.4.2 Mexico | | |
    3. 4.6.4.3 Argentina | | |
    4. 4.6.4.4 Rest of South America | |
  5. 4.6.5 MEA | | |
    1. 4.6.5.1 GCC Countries | | |
    2. 4.6.5.2 South Africa | | |
    3. 4.6.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Fresenius Medical Care (DE) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Baxter International (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Nipro Corporation (JP) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Asahi Kasei Medical (JP) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Medtronic (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Terumo Corporation (JP) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Dialysis Clinic, Inc. (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Kawasumi Laboratories (JP) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Grifols (ES) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies | |
  10. 5.2.10 Hemocue (SE) | | |
    1. 5.2.10.1 Financial Overview | | |
    2. 5.2.10.2 Products Offered | | |
    3. 5.2.10.3 Key Developments | | |
    4. 5.2.10.4 SWOT Analysis | | |
    5. 5.2.10.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY APPLICATION |
7. 6.4 US MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
8. 6.5 US MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
9. 6.6 US MARKET ANALYSIS BY END USER |
10. 6.7 US MARKET ANALYSIS BY PORTABILITY |
11. 6.8 CANADA MARKET ANALYSIS BY APPLICATION |
12. 6.9 CANADA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
13. 6.10 CANADA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
14. 6.11 CANADA MARKET ANALYSIS BY END USER |
15. 6.12 CANADA MARKET ANALYSIS BY PORTABILITY |
16. 6.13 EUROPE MARKET ANALYSIS |
17. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION |
18. 6.15 GERMANY MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
19. 6.16 GERMANY MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
20. 6.17 GERMANY MARKET ANALYSIS BY END USER |
21. 6.18 GERMANY MARKET ANALYSIS BY PORTABILITY |
22. 6.19 UK MARKET ANALYSIS BY APPLICATION |
23. 6.20 UK MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
24. 6.21 UK MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
25. 6.22 UK MARKET ANALYSIS BY END USER |
26. 6.23 UK MARKET ANALYSIS BY PORTABILITY |
27. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION |
28. 6.25 FRANCE MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
29. 6.26 FRANCE MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
30. 6.27 FRANCE MARKET ANALYSIS BY END USER |
31. 6.28 FRANCE MARKET ANALYSIS BY PORTABILITY |
32. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION |
33. 6.30 RUSSIA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
34. 6.31 RUSSIA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
35. 6.32 RUSSIA MARKET ANALYSIS BY END USER |
36. 6.33 RUSSIA MARKET ANALYSIS BY PORTABILITY |
37. 6.34 ITALY MARKET ANALYSIS BY APPLICATION |
38. 6.35 ITALY MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
39. 6.36 ITALY MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
40. 6.37 ITALY MARKET ANALYSIS BY END USER |
41. 6.38 ITALY MARKET ANALYSIS BY PORTABILITY |
42. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION |
43. 6.40 SPAIN MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
44. 6.41 SPAIN MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
45. 6.42 SPAIN MARKET ANALYSIS BY END USER |
46. 6.43 SPAIN MARKET ANALYSIS BY PORTABILITY |
47. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
48. 6.45 REST OF EUROPE MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
49. 6.46 REST OF EUROPE MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
50. 6.47 REST OF EUROPE MARKET ANALYSIS BY END USER |
51. 6.48 REST OF EUROPE MARKET ANALYSIS BY PORTABILITY |
52. 6.49 APAC MARKET ANALYSIS |
53. 6.50 CHINA MARKET ANALYSIS BY APPLICATION |
54. 6.51 CHINA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
55. 6.52 CHINA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
56. 6.53 CHINA MARKET ANALYSIS BY END USER |
57. 6.54 CHINA MARKET ANALYSIS BY PORTABILITY |
58. 6.55 INDIA MARKET ANALYSIS BY APPLICATION |
59. 6.56 INDIA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
60. 6.57 INDIA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
61. 6.58 INDIA MARKET ANALYSIS BY END USER |
62. 6.59 INDIA MARKET ANALYSIS BY PORTABILITY |
63. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION |
64. 6.61 JAPAN MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
65. 6.62 JAPAN MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
66. 6.63 JAPAN MARKET ANALYSIS BY END USER |
67. 6.64 JAPAN MARKET ANALYSIS BY PORTABILITY |
68. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
69. 6.66 SOUTH KOREA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
70. 6.67 SOUTH KOREA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
71. 6.68 SOUTH KOREA MARKET ANALYSIS BY END USER |
72. 6.69 SOUTH KOREA MARKET ANALYSIS BY PORTABILITY |
73. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION |
74. 6.71 MALAYSIA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
75. 6.72 MALAYSIA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
76. 6.73 MALAYSIA MARKET ANALYSIS BY END USER |
77. 6.74 MALAYSIA MARKET ANALYSIS BY PORTABILITY |
78. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION |
79. 6.76 THAILAND MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
80. 6.77 THAILAND MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
81. 6.78 THAILAND MARKET ANALYSIS BY END USER |
82. 6.79 THAILAND MARKET ANALYSIS BY PORTABILITY |
83. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION |
84. 6.81 INDONESIA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
85. 6.82 INDONESIA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
86. 6.83 INDONESIA MARKET ANALYSIS BY END USER |
87. 6.84 INDONESIA MARKET ANALYSIS BY PORTABILITY |
88. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION |
89. 6.86 REST OF APAC MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
90. 6.87 REST OF APAC MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
91. 6.88 REST OF APAC MARKET ANALYSIS BY END USER |
92. 6.89 REST OF APAC MARKET ANALYSIS BY PORTABILITY |
93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
94. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION |
95. 6.92 BRAZIL MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
96. 6.93 BRAZIL MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
97. 6.94 BRAZIL MARKET ANALYSIS BY END USER |
98. 6.95 BRAZIL MARKET ANALYSIS BY PORTABILITY |
99. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION |
100. 6.97 MEXICO MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
101. 6.98 MEXICO MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
102. 6.99 MEXICO MARKET ANALYSIS BY END USER |
103. 6.100 MEXICO MARKET ANALYSIS BY PORTABILITY |
104. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION |
105. 6.102 ARGENTINA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
106. 6.103 ARGENTINA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
107. 6.104 ARGENTINA MARKET ANALYSIS BY END USER |
108. 6.105 ARGENTINA MARKET ANALYSIS BY PORTABILITY |
109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY PORTABILITY |
114. 6.111 MEA MARKET ANALYSIS |
115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY END USER |
119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY PORTABILITY |
120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY END USER |
124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY PORTABILITY |
125. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION |
126. 6.123 REST OF MEA MARKET ANALYSIS BY BLOOD PURIFICATION TYPE |
127. 6.124 REST OF MEA MARKET ANALYSIS BY BLOOD FILTER MATERIAL |
128. 6.125 REST OF MEA MARKET ANALYSIS BY END USER |
129. 6.126 REST OF MEA MARKET ANALYSIS BY PORTABILITY |
130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
131. 6.128 RESEARCH PROCESS OF MRFR |
132. 6.129 DRO ANALYSIS OF HEALTHCARE |
133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
136. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
137. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
138. 6.135 HEALTHCARE, BY BLOOD PURIFICATION TYPE, 2024 (% SHARE) |
139. 6.136 HEALTHCARE, BY BLOOD PURIFICATION TYPE, 2024 TO 2035 (USD Billion) |
140. 6.137 HEALTHCARE, BY BLOOD FILTER MATERIAL, 2024 (% SHARE) |
141. 6.138 HEALTHCARE, BY BLOOD FILTER MATERIAL, 2024 TO 2035 (USD Billion) |
142. 6.139 HEALTHCARE, BY END USER, 2024 (% SHARE) |
143. 6.140 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
144. 6.141 HEALTHCARE, BY PORTABILITY, 2024 (% SHARE) |
145. 6.142 HEALTHCARE, BY PORTABILITY, 2024 TO 2035 (USD Billion) |
146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
147. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.2.5 BY PORTABILITY, 2025-2035 (USD Billion) |
149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.3.5 BY PORTABILITY, 2025-2035 (USD Billion) |
150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.4.5 BY PORTABILITY, 2025-2035 (USD Billion) |
151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.5.5 BY PORTABILITY, 2025-2035 (USD Billion) |
152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.6.5 BY PORTABILITY, 2025-2035 (USD Billion) |
153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.7.5 BY PORTABILITY, 2025-2035 (USD Billion) |
154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.8.5 BY PORTABILITY, 2025-2035 (USD Billion) |
155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.9.5 BY PORTABILITY, 2025-2035 (USD Billion) |
156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.10.5 BY PORTABILITY, 2025-2035 (USD Billion) |
157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.11.5 BY PORTABILITY, 2025-2035 (USD Billion) |
158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.12.5 BY PORTABILITY, 2025-2035 (USD Billion) |
159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.13.5 BY PORTABILITY, 2025-2035 (USD Billion) |
160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.14.5 BY PORTABILITY, 2025-2035 (USD Billion) |
161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.15.5 BY PORTABILITY, 2025-2035 (USD Billion) |
162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.16.5 BY PORTABILITY, 2025-2035 (USD Billion) |
163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.17.5 BY PORTABILITY, 2025-2035 (USD Billion) |
164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.18.5 BY PORTABILITY, 2025-2035 (USD Billion) |
165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.19.5 BY PORTABILITY, 2025-2035 (USD Billion) |
166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.20.5 BY PORTABILITY, 2025-2035 (USD Billion) |
167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.21.5 BY PORTABILITY, 2025-2035 (USD Billion) |
168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.22.5 BY PORTABILITY, 2025-2035 (USD Billion) |
169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.23.5 BY PORTABILITY, 2025-2035 (USD Billion) |
170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.24.5 BY PORTABILITY, 2025-2035 (USD Billion) |
171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.25.5 BY PORTABILITY, 2025-2035 (USD Billion) |
172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.26.5 BY PORTABILITY, 2025-2035 (USD Billion) |
173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.27.5 BY PORTABILITY, 2025-2035 (USD Billion) |
174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.28.5 BY PORTABILITY, 2025-2035 (USD Billion) |
175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.29.5 BY PORTABILITY, 2025-2035 (USD Billion) |
176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY BLOOD PURIFICATION TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY BLOOD FILTER MATERIAL, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.30.5 BY PORTABILITY, 2025-2035 (USD Billion) |
177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
178. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

Dialysis
Hemoperfusion
Plasmapheresis
Filtration

Healthcare By Blood Purification Type (USD Billion, 2025-2035)

Hemodialysis
Peritoneal Dialysis
Continuous Renal Replacement Therapy
Intermittent Hemodialysis

Healthcare By Blood Filter Material (USD Billion, 2025-2035)

Polyarylethersulfone
Cellulose Cellulose Acetate
Polyethersulfone
Polysulfone

Healthcare By End User (USD Billion, 2025-2035)

Hospitals
Dialysis Clinics
Ambulatory Care Centers
Home Use

Healthcare By Portability (USD Billion, 2025-2035)

Portable
Non-Portable

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”